PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12816347-5	2003	Drug molecules such as oral active beta-lactam antibiotics, bestatin, prodrugs of aciclovir and ganciclovir have oral bioavailabilities, which largely are a result of their interaction with PepT1.	Ganciclovir	96-107	solute carrier family 15 member 1	Homo sapiens	190-195	
15482169-3	2004	Valganciclovir is a highly recognized substrate of the intestinal peptide transporter PEPT1, which underlies the tenfold higher bioavailability of ganciclovir after valganciclovir compared to oral ganciclovir administration.	Ganciclovir	3-14	solute carrier family 15 member 1	Homo sapiens	86-91	
15482169-3	2004	Valganciclovir is a highly recognized substrate of the intestinal peptide transporter PEPT1, which underlies the tenfold higher bioavailability of ganciclovir after valganciclovir compared to oral ganciclovir administration.	Ganciclovir	147-158	solute carrier family 15 member 1	Homo sapiens	86-91	
10824137-0	2000	Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.	Ganciclovir	16-27	solute carrier family 15 member 1	Homo sapiens	77-82	
10824137-2	2000	We investigated the role of the intestinal peptide transporter PEPT1 in this process by comparing the interaction of ganciclovir and valganciclovir with the transporter in different experimental systems.	Ganciclovir	117-128	solute carrier family 15 member 1	Homo sapiens	63-68	
10824137-9	2000	Valganciclovir, but not ganciclovir, induced inward currents in PEPT1-expressing oocytes.	Ganciclovir	3-14	solute carrier family 15 member 1	Homo sapiens	64-69	
24943988-2	2015	Reports from our laboratory have suggested that dipeptide ester prodrugs of GCV exhibit high affinity towards the oligopeptide transporter hPEPT1 and therefore seem to be promising candidates for the treatment of oral herpes virus infections.	Ganciclovir	76-79	solute carrier family 15 member 1	Homo sapiens	139-145